Multiple Site Management Strategies – Amy Henderson Featured in Q&A with International Clinical Trials
Leading Multi-Site Research: Maximizing Efficiency and Reducing Turnover International Clinical Trials, August 2024, pages 95-97. © Samedan Ltd Managing multiple clinical research sites can be challenging, but with the right strategies, it’s entirely achievable. Effective management is key to reducing turnover, streamlining operations, and ensuring smooth research progress across locations. Amy Henderson speaks with International Clinical Trials about how a multi-site research business maximizes efficiency by harnessing challenges as opportunities. Learn best practices for resource allocation, team unification, and technology integration. Discover actionable insights on reducing turnover, standardizing procedures, and creating a motivated, cohesive team. Read Article
Paradigm Clinical Research Expands into Modesto, Increasing Clinical Trial Opportunities in California’s Critically Underserved Central Valley Corridor
Paradigm Clinical Research announces the opening of its newest clinical research site in Modesto, California. This expansion aligns with our mission to serve communities historically underrepresented in clinical trials. The Modesto clinic represents another example of Paradigm Clinical Research’s operating playbook and de novo expansion strategy. Modesto represents a strategic addition to our footprint, aiming to provide access to clinical trials across the Central Valley region. Our decision to establish a presence in Modesto was driven by the area’s demographic diversity and profound lack of any other professionally managed clinical trial businesses. Our goal in Modesto is to create a robust clinical research ecosystem that supports both study sponsors and the local community. The expansion in Modesto complements Paradigm Clinical Research’s long standing clinic further north in Redding, CA and the company’s strategic interests in the intermediate markets including Sacramento and beyond. This development follows our successful clinic openings in Boise, Idaho, and our flagship site in San Diego. It underscores our mission to provide opportunities to advance the human condition through participation in clinical research.
Paradigm Clinical Research Opens Its Flagship Clinic in San Diego, Marking 15 Years of Success
Paradigm Clinical Research, a leading clinical research site business, announced the opening of its flagship clinic in San Diego, California coinciding with the celebration of the company’s 15th anniversary. This is a significant milestone in the company’s growth strategy, positioning its flagship site to better serve the evolving needs of patients and the clinical research community. “The opening of our flagship clinic solidifies Paradigm Clinical Research’s position at the forefront of the multi-location and multi-specialty clinical research site market,” said Kurt Mussina, CEO of Paradigm Clinical Research. “Our operating model is ‘one site offering many locations and investigators,’ meaning all our clinics and staff function under a single, harmonized set of operating standards and principles. This positions us well to deliver industry-leading value to all stakeholders, especially patients, as evidenced by our exceptional patient Net Promoter Score® of 96. The opening of our San Diego clinic not only aligns with a decade and a half of success, but also validates our unique operating and growth strategies.” “We are proud of the success the entire Paradigm Clinical Research team has achieved, including the opening of the company’s flagship clinic,” said Aleem Choudhry, Managing Partner at Crane Street Capital. “This highlights the strength of the team’s managerial and operational expertise, providing the company with an even greater ability to meet the needs of clinical trial sponsors on so many different levels.” Paradigm Clinical Research celebrates its 15th anniversary this year, marking a decade and a half of success supporting industry sponsored clinical trials. The company remains committed to fostering diversity and inclusion and boasts access to a distinguished team of principal investigators across several therapeutic areas and specialties. For more information about Paradigm Clinical Research and its services, please visit paradigm-research.com. About Paradigm Clinical Research Paradigm Clinical Research is a long-standing clinical research site business with locations in California, Colorado, and Idaho. The company operates wholly owned sites that support Phase I-IV clinical trials and provides sponsors with access to diverse and often under-represented patient populations and investigators. Paradigm’s mission is to enrich lives by offering opportunities to advance the human condition through participation in expertly conducted clinical trials. To learn more, please visit paradigm-research.com. About Crane Street Capital Group Crane Street Capital Group specializes in micro growth buyouts in a few selected fragmented industries with untapped white space potential for growth. Its investments target companies that not only have outsized growth potential within their industries but also have the ability to make tremendously positive impacts within the communities in which they operate. Crane Street maintains a concentrated portfolio, deploys capital on an independent basis when outstanding opportunities are available and implements a patient approach in value creation over typically 5+-year holding periods. Currently, there are seven companies in the portfolio, four of which are in education services and three of which are in healthcare services.
Paradigm Clinical Research Expands Into Boise, Idaho, Advancing the Company’s Portfolio of Therapeutic Area Expertise
Paradigm Clinical Research, a leading clinical research site business, announces the opening of its latest clinical research site in Boise, Idaho. February 8, 2024 – This marks a significant milestone as the company establishes its first site in Idaho, further advancing its footprint and its portfolio of therapeutic areas including women’s health studies. This emphasizes Paradigm Clinical Research’s commitment to making meaningful differences in the lives of the individuals and communities the company serves. The Boise site complements the company’s existing locations, reinforcing Paradigm Clinical Research’s dedication to establishing purpose-built research sites that cater to the growing demand for study participants and the crucial need for diverse populations and investigators. The expansion in Boise includes the company’s growing roster of partner investigators, including Dr. Keri Erland, Dr. Kelly Siudzinski, Dr. Tara Erbele, and Dr. Roger Wyatt, all playing pivotal roles in bringing clinical trial opportunities to the greater Treasure Valley community. Kurt Mussina, CEO of Paradigm Clinical Research, emphasized the unique aspect of this expansion, stating, “Boise represents more than a geographic extension for us; it’s an opportunity to make further strides in women’s health and our other therapeutic areas of interest. We are not merely opening a new location; we are expanding our commitment to advancing healthcare, particularly in areas that matter most to the community.”
San Diego NBC 7 Cytomegalovirus (CMV) Article
Cytomegalovirus (CMV) is making headlines, and it’s behind a majority of US birth defects. The virus spreads through fluids, making it a serious concern for expectant parents. As we uncover more about this alarming situation, it’s crucial to stay informed and take necessary precautions to protect ourselves and our loved ones. Watch or read more in San Diego NBC 7’s “‘It’s spread with fluids’: Little-known virus behind majority of US birth defects” article. Paradigm Clinical Research is currently enrolling participants for a CMV vaccine study. Submit a form to learn more by filling out our join a study form. Knowledge is power, and understanding the risks empowers us to make informed decisions. Let’s share this important article to raise awareness and support clinical research efforts to combat this health challenge. Together, we can strive for a safer and healthier future for generations to come. Because Better Medicines Matter More Than Ever.